MedTrace Logo

Case Management in HCV Infected PWID

NCT03106194 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 441

Last updated 2020-01-27

No results posted yet for this study

Summary

To study the impact of case management on the outcome of the care of chronic hepatitis C in people who inject drugs (PWID). By creating the function of case manager, the investigators will target all the barriers to care of the HCV care continuum. Partial objectives are to measure the impact of case management on the uptake for screening, the uptake and outcome of treatment, and the rate of reinfection.

Conditions

  • Drug Abuse, Intravenous

Interventions

OTHER

case management

Sponsors & Collaborators

  • Ziekenhuis Oost-Limburg

    collaborator OTHER

  • CAD Limburg

    collaborator UNKNOWN

  • Hasselt University

    lead OTHER

Principal Investigators

  • Geert Robaeys, prof. dr. · Hasselt University

  • Rob Bielen, drs. · Hasselt University

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03106194 on ClinicalTrials.gov